Mankind Pharma Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 72.62% of Mankind Pharma, FIIs hold 9.37%, DIIs hold 15.54% and the public holds 2.46%. Promoter holding fell by 0.01 percentage points from Jun 2026.

Get an alert when Mankind Pharma reports results or its shareholding changes. Free account.

Promoters

72.62%

−0.01 pp QoQ

FIIs

9.37%

−0.08 pp QoQ

DIIs

15.54%

+0.15 pp QoQ

Public

2.46%

−0.07 pp QoQ

Mankind Pharma shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicShareholders
Sep 202672.62%9.37%15.54%2.46%1,63,770
Jun 202672.63%9.45%15.39%2.53%1,66,715
Mar 202672.66%10.24%14.46%2.63%1,77,606
Dec 202572.66%11.34%13.26%2.75%1,77,539
Sep 202572.67%12.83%11.91%2.57%1,70,347
Jun 202572.67%13.07%11.50%2.75%1,79,549
Mar 202572.70%12.92%11.47%2.89%1,80,597
Dec 202472.71%13.34%11.05%2.89%1,71,281
Sep 202474.87%12.37%9.91%2.86%1,63,854
Jun 202474.87%11.58%9.94%3.61%1,53,450
Mar 202474.88%9.87%11.14%4.10%1,35,116
Dec 202376.50%6.74%9.78%6.97%1,27,449

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹1.09 lakh cr, the promoter group's 72.62% stake is worth ₹79.19k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Mankind Pharma shareholding: common questions

What is the promoter holding in Mankind Pharma?

Promoters hold 72.62% of Mankind Pharma as of Sep 2026. Their stake fell by 0.01 percentage points from Jun 2026.

How much do FIIs hold in Mankind Pharma?

Foreign institutional investors (FIIs) held 9.37% of Mankind Pharma in Sep 2026, −0.08 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in Mankind Pharma?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 15.54% of Mankind Pharma in Sep 2026, +0.15 pp versus Jun 2026.

Is the promoter holding in Mankind Pharma pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Mankind Pharma.

How has Mankind Pharma's promoter holding changed in the last year?

Promoter holding moved from 72.67% in Sep 2025 to 72.62% in Sep 2026 (−0.05 pp).

How many shareholders does Mankind Pharma have?

Mankind Pharma had 1,63,770 shareholders in Sep 2026, compared with 1,66,715 in Jun 2026.